Dihydroquercetin as potential immunonutrient in treatment of COVID-19
https://doi.org/10.33667/2078-5631-2021-21-28-32
Abstract
The main aspects of the antiviral, anti-inflammatory, antioxidant and hepatoprotective properties of dihydroquercetin (DHQ), which may affect the course of COVID-19, are considered. Given the low toxicity and a wide range of biological activity, aimed not only at suppressing enzymatic reactions with the participation of coronavirus, but also at eliminating the lesions caused by it in all the main target organs, dihydroquercetin can be recommended for inclusion in the complex therapy of the disease and during the recovery period of COVID-19.
About the Authors
V. V. TatarinovRussian Federation
Vasiliy V. Tatarinov - head of Nanofit Co., employee of Group of Electron Probe Microanalysis of Laboratory of X-ray Methods of Analysis.
Irkutsk.
S. V. Orlova
Russian Federation
Svetlana V. Orlova - DM Sci, professor, head of Dept of Dietetics and Clinical Nutritiology.
Moscow.
E. A. Nikitina
Russian Federation
Elena A. Nikitina - PhD Med, assistant professor at Dept of Dietetics and Clinical Nutritiology.
Moscow.
E. V. Prokopenko
Russian Federation
Elena V. Prokopenko - endocrinologist, nutritionist, methodologist of Medical Dept.
Moscow.
A. N. Vodolazkaya
Russian Federation
Angelina N. Vodolazkaya - nutritionist-endocrinologist.
Moscow.
Yu. A. Pigareva
Russian Federation
Yulia A. Pigareva - PhD Med, head of Dept of Clinical Dietetics.
Moscow.
K. V. Paliy
Russian Federation
Konstantin V. Paliy - independent nutritionist, master in pharmaceutical management.
References
1. Antonio A. D.S. et al. Natural products' role against COVID-19. RSC Adv. 2020. Vol. 10. N 39. P. 23379-23393. DOI: https://doi.org/10.1039/D0RA03774E
2. Islm M.T et al. Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data. Phytother. Res. 2020. Vol 34. N 10. P. 2471-2492. DOI: https://doi.org/10.1002/ptr.6700
3. Gogoi N. et al. Computational guided identification of a citrus flavonoid as potential inhibitor of SARS-CoV-2 main protease. Mol. Divers. 2020. DOI: https://doi.org/10.1007/s11030-020-10150-x
4. Fischer A. et al. Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds. Int. J. Mol. Sci. 2020. Vol. 21. N 10. Article 3626. DOI: https://doi.org/10.3390/ijms21103626
5. Tyukavkina N. A., Lapteva K. I., Medvedeva S. A. Phenolic extractives of the genus Larix. Wood chemistry. 1973. Issue. 13, pp. 3-17.
6. Babkin V. A., Ostroumova L. A., Dyachkova S. G., Svyatkin Yu.K., Babkin D. V., Onuchina N. A. Waste-free complex processing of Siberian and Dahurian larch biomass. Chemistry for Sustainable Development. 1997. No. 5. P. 105-115.
7. Tyukavkina N. A., Rudenko I. A., Kolesnik Yu. A. Natural flavonoids as biological antioxidants and dietary supplements. Nutrition issues. 1996. No. 2. P. 33-38.
8. Tyukavkina N. A., Rudenko I. A., Kolesnik Yu. A. Dihydroquercetin is a new antioxidant and dietary supplement. Nutrition issues. 1997. No. 6. P. 12-15.
9. Plotnikov M. B., Tyukavkina N. A., Plotnikova T. M. Medicines based on divertin. Tomsk, 2005. 245 p.
10. Shchukina O. G., Yushkova G. G., Chernyak Yu. I. Investigation of the processes of peroxidation in the body of animals with oral administration of dihydroquercetin. Siberian medical journal. 2008. No. 4. P. 46-48.
11. L. V. Kravchenko and other Assessment of antioxidant and antitoxic effectiveness of natural flavonoid dihydroquercetin. Toxicol. vestn. 2005. No. 1. P. 14-20.
12. Potapovich A. I., Kostyuk V. A. Comparative study of antioxidant properties and cytoprotective activity of flavonoids. Biochemistry. 2003. T. 68. No. 5. P. 632-638.
13. Kostyrya O. V., Korneeva O. S. On the prospects for the use of dihydroquercetin in the production of products with a prolonged shelf life. Vestn. VSUIT. 2015. No. 4 (66). P. 165-170.
14. Galochkina A. V. et al. Study of the antiviral activity of dihydroquercetin during replication of the Coxsackie B 4 virus in vitro. Virology issues. 2016.Vol. 61. No. 1. P. 27-31. URL: https://www.elibrary.ru/item.asp?id=25968037
15. Galochkina A. V. et al. Virus-inhibiting activity of dihydroquercetin, a flavonoid from Larix sibirica, against coxsackievirus B 4 in a model of viral pancreatitis. Arch. Virol. 2016. 161 (4), P. 929-938. DOI: https://doi.org/10.1007/s00705-016-2749-3
16. V. V. Zarubaev and others. Antiviral drugs based on biologically active substances from larch wood. Bulletin VSNTS SB RAMS. 2010. No. 1 (71). P. 76-80.
17. Kolhir V. K. et al. Use of a new antioxidant diquertin as an adjuvant in the therapy of patients with acute pneumonia. Phytother. Res. 1998. Vol. 12. N 8. P. 606-608. DOI: https://doi.org/10.1002/(SICI)1099-1573(199812)12:8%3C606::AID-PTR367%3E3.0.CO;2-U
18. Teselkin Yu.O. et al. The use of a new antioxidant agent divertin in the treatment of patients with acute pneumonia. Questions of biological, medical and pharmaceutical chemistry. 1999. No. 1. P. 36-40.
19. Plotnikov M. B., Tyukavkina N. A., Plotnikova T. M. Medicines based on divertin. Tomsk: Publishing house of Vol. University, 2005. 228 p.
20. Danilenko S. A. Correction of microcirculation disorders with dihydroquercetin in patients with chronic obstructive pulmonary disease. Siberian medical journal. 2010. T. 94. No. 3. P. 59-62.
21. Bizyuk L. A., Korolevich M. P. Antioxidant dihydroquercetin: clinical and pharmacological efficacy and synthesis routes. Medical business: scientific and practical therapeutic journal. 2013. No. 1. P. 13-19. URL: https://www.elibrary.ru/item.asp?id=23878287
22. A. A. Kubatiev and others. Diquertin is an effective inhibitor of platelet aggregation of flavonoid nature. Questions of biological, medical and pharmaceutical chemistry. 1999. No. 3. P. 47-51.
23. Kolkhir V. K. and others. Dikvertin is a new antioxidant and capillary-protective agent. Chem.-pharmacist Journal. 1995. T. 29. No. 9. P. 61-64.
24. E. A. Tarasova The use of a new antioxidant drug Dikvertin in the treatment of patients with coronary heart disease. Practice. Phytoter. 1999. No. 1. P. 37-41.
25. Theriault A. et al. Modulation of hepatic lipoprotein synthesis and secretion by taxifolin, a plant flavonoid. J. Lipid Res. 2000. Vol. 41. N 12. P. 1969-1979. DOI: https://doi.org/10.1016/S00222275(20)32358-0
26. Delgado-Roche L., Mesta F. Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection. Arch. Med. Res. 2020. Vol. 51. N 5. P. 384-387. DOI: https://doi.org/10.1016/j.arcmed.2020.04.019
27. Cecchini R., Cecchini A. L. SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression. Med. Hypotheses. 2020. Vol. 143. Article 110102. DOI: https://doi.org/10.1016/j.mehy.2020.110102
28. Beltran-Garda J. et al. Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression. Antioxidants. 2020. Vol. 9. No. 10. Article 936. DOI: https://doi.org/10.3390/antiox9100936
29. Mironova G. D. et al. Prospects for the use of regulators of oxidative stress in the comprehensive treatment of the novel Coronavirus Disease 2019 (COVID-19) and its complications. Eur. Rev. Med. Pharmacol. Sci. 2020. Vol. 24. N 16. P. 8585-8591. DOI: https://doi.org/10.26355/eurrev_202008_22658
30. Khairullina V. R. et al. Determination of the antioxidant effect of quercetin and dihydroquercetin in binary compositions. Chemistry of plant raw materials. 2008. No. 4. P. 59-64.
31. Teselkin Yu.O. and other Antioxidant properties of dihydroquercetin. Biophysics. 1996. T. 41. No. 3. P. 621-624.
32. Li X.et al. The mechanism of (+) taxifolin's protective antioxidant effect for •OH-treated bone marrow-derived mesenchymal stem cells. Cell. Mol. Biol. Lett. 2017. Vol. 22. N 1. P. 1-11. DOI: https://doi.org/10.1186/s11658-017-0066-9
33. Rong Y. et al. A theoretical study on cellular antioxidant activity of selected flavonoids. Spectrochim. Acta A. 2012. Vol. 93. P. 235-239. DOI: https://doi.org/10.1016/j.saa.2012.03.008
34. Topal F. et al. Antioxidant activity of taxifolin: an activity-structure relationship. Journal of Enzyme Inhibition and Medicinal Chemistry. 2016. Vol. 31. No. 4. pp. 674-683. DOI 10.3109/14756366.2015.1057723
35. Shubina V. S., Shatalin Y. V. Antioxidant and iron-chelating properties of taxifolin and its condensation product with glyoxylic acid. Journal of food science and technology. 2017. Vol. 54. No. 6. pp. 1467-1475. DOI 10.1007/s13197-017-2573-0
36. Babenkova I. V., Osipov A. N., Teselkin Y. O. The Effect of Dihydroquercetin on Catalytic Activity of Iron (II) Ions in the Fenton Reaction. Bulletin of Experimental Biology and Medicine. 2018. pp. 347-350. DOI 10.1007/s10517-018-4167-x
37. Salama S. A., Kabel A. M. Taxifolin ameliorates iron overload-induced hepatocellular injury: Modulating PI3K/AKT and p38 MAPK signaling, inflammatory response, and hepatocellular regeneration. Chemico-biological interactions. 2020. Vol. 330. Article 109230. DOI 10.1016/j.cbi.2020.109230
38. Yang C. J. et al. UHPLC-MS/MS determination, pharmacokinetic, and bioavailability study of taxifolin in rat plasma after oral administration of its nanodispersion. Molecules. 2016. Vol. 21. No. 4. Article 494. DOI 10.3390/molecules21040494
39. Alves M. C. et al. Taxifolin: evaluation through ex vivo permeations on human skin and porcine vaginal mucosa. Current drug delivery. 2018. Vol. 15. No. 8. pp. 1123-1134. DOI 10.2174/1567201815666180116090258
40. N. V. Naumenko and others. Possibilities of regulating the stress-protective properties of food to enhance the immunity of the human body in the context of the COVID-19 pandemic. Man. Sport. The medicine. 2020.Vol. 20. No. S 1. P. 116-127. DOI 10.14529/hsm20s115
Review
For citations:
Tatarinov V.V., Orlova S.V., Nikitina E.A., Prokopenko E.V., Vodolazkaya A.N., Pigareva Yu.A., Paliy K.V. Dihydroquercetin as potential immunonutrient in treatment of COVID-19. Medical alphabet. 2021;(21):28-32. (In Russ.) https://doi.org/10.33667/2078-5631-2021-21-28-32